Thanks for all the reports.
As for "They are in no rush, and that may well be in our long term interest.". Big pharma may well be in a rush, as it is probably in their interest to get access to CAVATAK and stop their competitors from getting it.
There are some very exciting months coming up imho.
- Forums
- ASX - By Stock
- VLA
- AGM notes from a non-medic.
AGM notes from a non-medic., page-14
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)